Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China flag China · Delayed Price · Currency is CNY
17.30
+0.27 (1.59%)
Apr 29, 2026, 3:00 PM CST
57.56%
Market Cap 7.28B
Revenue (ttm) 719.17M
Net Income (ttm) -19.53M
Shares Out 420.78M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,251,397
Average Volume 16,807,568
Open 16.89
Previous Close 17.03
Day's Range 16.77 - 17.55
52-Week Range 10.27 - 22.55
Beta 0.51
RSI 46.24
Earnings Date Mar 31, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 735
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688488
Full Company Profile

Financial Performance

In 2025, SHA:688488's revenue was 719.17 million, an increase of 72.13% compared to the previous year's 417.80 million. Losses were -19.53 million, -86.17% less than in 2024.

Financial Statements

News

There is no news available yet.